PDL BioPharma (PDLI) Tops Q2 View
Tweet Send to a Friend
PDL BioPharma (Nasdaq: PDLI) reports Q2 EPS of $0.35, versus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
